Litigation Details for ALLERGAN SALES, LLC v. SANDOZ, INC. (D.N.J. 2017)
✉ Email this page to a colleague
ALLERGAN SALES, LLC v. SANDOZ, INC. (D.N.J. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-10-30 |
| Court | District Court, D. New Jersey | Date Terminated | 2022-01-28 |
| Cause | 35:271 Patent Infringement | Assigned To | Claire Claudia Cecchi |
| Jury Demand | Both | Referred To | Edward S. Kiel |
| Parties | HON. DENNIS M. CAVANAUGH | ||
| Patents | 7,030,149; 7,320,976; 7,323,463; 7,642,258; 8,133,890; 8,354,409; 8,748,425; 9,474,751; 9,770,453; 9,907,801; 9,907,802 | ||
| Attorneys | HECTOR DANIEL RUIZ | ||
| Firms | Eric I. Abraham | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in ALLERGAN SALES, LLC v. SANDOZ, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for ALLERGAN SALES, LLC v. SANDOZ, INC. (D.N.J. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2017-10-30 | 1 | formulation of Combigan®. The listed patents are U.S. Patent Nos. 7,030,149, 7,320,976, 7,642,258, 8,133,890…infringed U.S. Patent Nos. 7,030,149, 7,320,976, 7,323,463, and 7,642,258, and that those patents were not …latest of the expiration dates of U.S. Patent Nos. 7,030,149, 7,320,976, 7,323,463, and 7,642,258. …that the claims of the ’149 patent, ’258 patent, ’976 patent, and ’425 patent are invalid and/or will not… infringement of United States Patent No. 9,770,453 (the “’453 patent”) under 35 U.S.C. § 271(e)(2) and | External link to document | |
| 2018-05-22 | 112 | the first patent from which issued in 2006, U.S. Patent No. 7,030,149 (the “’149 patent”). (Id. ¶¶…the “’801 patent”), and 9,907,802 (the “’802 patent). These patents all stem from a patent application… ’149 patent, the ’425 patent, and a third patent from the first litigation, the ’976 patent. 6 (Id…other patents, U.S. Patent Nos. 8,133,890 (the “’890 patent”) and 8,354,409 (the “’409 patent”) that…Allergan Patent Family beginning with the first patent of this family, the ’149 patent. The inequitable | External link to document | |
| 2018-07-26 | 166 | Redacted Document | 149 patent U.S. Patent No. 7,030,149 (Ex. 5) °976 patent U.S. Patent No. 7,320,976 (Ex. 6) °258 patent U.S…methods of treatment. (32); see U.S. Pat. Nos. 7,030,149, 7,323,463, 8,133,890, 8,354,409, 8,748,425, 9,770,453…Apr. 13, 2012) °453 patent U.S. Patent No. 9,770,453 (Ex. 1) °801 patent U.S. Patent No. 9,907,801 (Ex.…Ex. 2) °802 patent U.S. Patent No. 9,907,802 (Ex. 3) °463 patent USS. Patent No. 7,323,463 (Ex. 4) °149… U.S. Patent No. 7,642,258 (Ex. 7) °409 patent U.S. Patent No. 8,354,409 (Ex. 8) °890 patent U.S. Patent | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
